Public Health Vaccines LLC

Experimental Vaccines and Therapeutics Deployed in Rwanda to Combat Marburg Outbreak

8 months ago

• Rwanda is set to begin clinical trials of experimental vaccines and therapeutics to combat a Marburg outbreak, which has seen 46 infections and 12 deaths. • The Sabin Vaccine Institute has delivered 700 doses of its Marburg vaccine for a Phase 2 trial targeting frontline health workers, with potential for further supply. • Gilead Sciences is donating 5,000 doses of remdesivir, an antiviral drug, for emergency use in Rwanda, alongside monoclonal antibody treatments from the U.S. government. • The WHO is supporting Rwanda in managing the outbreak, emphasizing the critical need for enhanced infection prevention and control measures to safeguard health workers.